Cargando…

Clinical challenges in cancer patients with COVID-19: Aging, immunosuppression, and comorbidities

COVID-19 caused by severe acute respiratory syndrome coronavirus 2 has developed into a global pandemic. COVID-19 poses a huge threat to health care, and the shortage of medical resources caused by COVID-19 brought serious secondary disasters to elderly cancer patients who are particularly dependent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lu, Sun, Yinan, Yuan, Ye, Mei, Qi, Yuan, Xianglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762454/ https://www.ncbi.nlm.nih.gov/pubmed/33232275 http://dx.doi.org/10.18632/aging.104205

Ejemplares similares

COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges
por: Pathania, Anup S., et al.
Publicado: (2021)

Artificial intelligence in clinical decision support systems for oncology
por: Wang, Lu, et al.
Publicado: (2023)

The challenge of comorbidity in clinical trials for multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Clinical perspectives on the age-related increase of immunosuppressive activity
por: Salminen, Antero
Publicado: (2022)

Comorbidities of COVID-19 Patients
por: Silaghi-Dumitrescu, Radu, et al.
Publicado: (2023)

Immunosuppression and Chagas Disease: A Management Challenge
por: Pinazo, María-Jesús, et al.
Publicado: (2013)

COVID-19 in Kidney Transplantation: Outcomes, Immunosuppression Management, and Operational Challenges
por: Abu Jawdeh, Bassam G.
Publicado: (2020)

Assessment of patients who tested positive for COVID-19 after recovery
por: Mei, Qi, et al.
Publicado: (2020)

Mental health problems among COVID‐19 survivors in Wuhan, China
por: Mei, Qi, et al.
Publicado: (2021)

Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities
por: Lu, Chen, et al.
Publicado: (2019)

Chemotherapy plus targeted drugs in conversion therapy for potentially resectable colorectal liver metastases: a meta-analysis
por: Wang, Lu, et al.
Publicado: (2016)

Liver transplant immunosuppression during the COVID-19 pandemic()
por: Forns, Xavier, et al.
Publicado: (2020)

Use of convalescent plasma in COVID‐19 patients with immunosuppression
por: Senefeld, Jonathon W., et al.
Publicado: (2021)

Immunosuppressant Therapies in COVID-19: Is the TNF Axis an Alternative?
por: Palacios, Yadira, et al.
Publicado: (2022)

The challenging interplay between rheumatoid arthritis, ageing and comorbidities
por: van Onna, Marloes, et al.
Publicado: (2016)

Challenges and Opportunities for Immunotherapeutic Intervention against Myeloid Immunosuppression in Glioblastoma
por: Exley, Mark A., et al.
Publicado: (2022)

Innovative immunosuppression in kidney transplantation: A challenge for unmet needs
por: Salvadori, Maurizio, et al.
Publicado: (2022)

The role of immunosuppressive myofibroblasts in the aging process and age-related diseases
por: Salminen, Antero
Publicado: (2023)

Systematic review of immunosuppressant guidelines in the COVID-19 pandemic
por: Barlow-Pay, Fenella, et al.
Publicado: (2021)

Immunosuppressant Management in Renal Transplant Patients with COVID-19
por: Ahmadian, Elham, et al.
Publicado: (2021)

COVID-19: biologic and immunosuppressive therapy in gastroenterology and hepatology
por: Neurath, Markus F.
Publicado: (2021)

Covid-19 in kidney transplant recipients with immunosuppressive therapy
por: Sheikhalipour, Zahra, et al.
Publicado: (2022)

Trilogy of COVID-19: Infection, Vaccination, and Immunosuppression
por: Mohanraj, Dinesh, et al.
Publicado: (2022)

The paradox of immunosuppressants and COVID-19
por: Cheng, Guang-Shing, et al.
Publicado: (2022)

COVID-19 in Immunosuppressed Children
por: Nicastro, Emanuele, et al.
Publicado: (2021)

Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: Risk, outcome, vaccination, and beyond
por: Mahmoudi, Hamidreza, et al.
Publicado: (2022)

Comorbid immunosuppression in Merkel cell carcinoma: A retrospective database study
por: Riviere, Paul, et al.
Publicado: (2022)

Immunosuppressive drugs for nontransplant comorbidities are not associated with abdominal aortic aneurysm growth
por: Thanigaimani, Shivshankar, et al.
Publicado: (2022)

Challenges and Recent Advancements in COVID-19 Vaccines
por: Wang, Shao-Cheng, et al.
Publicado: (2023)

Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis
por: Jain, Vageesh, et al.
Publicado: (2020)

Increased immunosuppression impairs tissue homeostasis with aging and age-related diseases
por: Salminen, Antero
Publicado: (2020)

Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions
por: Liu, Junfeng, et al.
Publicado: (2023)

Comorbidities and Age Are Associated With Persistent COVID-19 PCR Positivity
por: Aldhaeefi, Mohammed, et al.
Publicado: (2021)

Age, Comorbid Conditions, and Racial Disparities in COVID-19 Outcomes
por: Wiley, Zanthia, et al.
Publicado: (2021)

Advanced age, comorbidity and the risk of mortality in COVID-19 infection
por: Endeshaw, Yohannes, et al.
Publicado: (2022)

Comorbidity in social anxiety disorder: diagnostic and therapeutic challenges
por: Koyuncu, Ahmet, et al.
Publicado: (2019)

Clinical characteristics and prognosis of immunosuppressed inpatients with COVID-19 in Japan
por: Nomoto, Hidetoshi, et al.
Publicado: (2022)

The epidemiology of premature aging and associated comorbidities
por: Coppedè, Fabio
Publicado: (2013)

Atherosclerosis, Cardiovascular Disorders and COVID-19: Comorbid Pathogenesis
por: Makarova, Yulia A., et al.
Publicado: (2023)

Challenges of COPD Patients during the COVID-19 Pandemic
por: Sun, Sheng-Wen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_177181dt2t9g76df4nlcllkq55